Actyon Discovery, Inc.
Actyon Discovery, Inc. is a digital drug discovery company specializing in the design, validation, and advancement of new drugs based on novel scaffolds from unexplored chemistry. Their proprietary FreeRingSpace™ Platform combines decades of applied chemical synthesis experience with advanced AI-based compound selection and optimization tools to generate an ultra-large reaction space of billions of synthetically accessible drug-like molecules. This platform focuses on creating novel intellectual property free scaffolds, enabling the discovery of first-in-class small molecule treatments. Actyon synthesizes selected candidate molecules in wet labs and tests biological activity through partners and internal resources. Their approach surpasses traditional generative AI by forecasting chemical reactions beyond known drug-like chemical space, positioning them uniquely in the drug discovery market.
Actyon Discovery, Inc.
Actyon Discovery, Inc. is a digital drug discovery company specializing in the design, validation, and advancement of new drugs based on novel scaffolds from unexplored chemistry. Their proprietary FreeRingSpace™ Platform combines decades of applied chemical synthesis experience with advanced AI-based compound selection and optimization tools to generate an ultra-large reaction space of billions of synthetically accessible drug-like molecules. This platform focuses on creating novel intellectual property free scaffolds, enabling the discovery of first-in-class small molecule treatments. Actyon synthesizes selected candidate molecules in wet labs and tests biological activity through partners and internal resources. Their approach surpasses traditional generative AI by forecasting chemical reactions beyond known drug-like chemical space, positioning them uniquely in the drug discovery market.